GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Wuzhong Pharmaceutical Development Co Ltd (SHSE:600200) » Definitions » Cyclically Adjusted PS Ratio

Jiangsu Wuzhong Pharmaceutical Development Co (SHSE:600200) Cyclically Adjusted PS Ratio : 2.46 (As of Jun. 06, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Jiangsu Wuzhong Pharmaceutical Development Co Cyclically Adjusted PS Ratio?

As of today (2024-06-06), Jiangsu Wuzhong Pharmaceutical Development Co's current share price is ¥9.52. Jiangsu Wuzhong Pharmaceutical Development Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥3.87. Jiangsu Wuzhong Pharmaceutical Development Co's Cyclically Adjusted PS Ratio for today is 2.46.

The historical rank and industry rank for Jiangsu Wuzhong Pharmaceutical Development Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

SHSE:600200' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.86   Med: 1.92   Max: 7.32
Current: 2.61

During the past years, Jiangsu Wuzhong Pharmaceutical Development Co's highest Cyclically Adjusted PS Ratio was 7.32. The lowest was 0.86. And the median was 1.92.

SHSE:600200's Cyclically Adjusted PS Ratio is ranked better than
68.06% of 504 companies
in the Biotechnology industry
Industry Median: 5.525 vs SHSE:600200: 2.61

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Jiangsu Wuzhong Pharmaceutical Development Co's adjusted revenue per share data for the three months ended in Mar. 2024 was ¥0.973. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥3.87 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Jiangsu Wuzhong Pharmaceutical Development Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Jiangsu Wuzhong Pharmaceutical Development Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Wuzhong Pharmaceutical Development Co Cyclically Adjusted PS Ratio Chart

Jiangsu Wuzhong Pharmaceutical Development Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.95 1.02 1.84 1.77 2.10

Jiangsu Wuzhong Pharmaceutical Development Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.93 1.74 1.94 2.10 3.02

Competitive Comparison of Jiangsu Wuzhong Pharmaceutical Development Co's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Jiangsu Wuzhong Pharmaceutical Development Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Wuzhong Pharmaceutical Development Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jiangsu Wuzhong Pharmaceutical Development Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Jiangsu Wuzhong Pharmaceutical Development Co's Cyclically Adjusted PS Ratio falls into.



Jiangsu Wuzhong Pharmaceutical Development Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Jiangsu Wuzhong Pharmaceutical Development Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=9.52/3.87
=2.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Wuzhong Pharmaceutical Development Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Jiangsu Wuzhong Pharmaceutical Development Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.973/115.2271*115.2271
=0.973

Current CPI (Mar. 2024) = 115.2271.

Jiangsu Wuzhong Pharmaceutical Development Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1.153 98.200 1.353
201409 1.292 98.900 1.505
201412 1.122 99.000 1.306
201503 1.276 99.900 1.472
201506 0.951 99.500 1.101
201509 1.259 100.500 1.443
201512 1.140 100.600 1.306
201603 0.828 102.200 0.934
201606 1.166 101.400 1.325
201609 1.911 102.400 2.150
201612 1.902 102.600 2.136
201703 1.385 103.200 1.546
201706 1.140 103.100 1.274
201709 0.782 104.100 0.866
201712 0.808 104.500 0.891
201803 0.781 105.300 0.855
201806 0.584 104.900 0.641
201809 0.566 106.600 0.612
201812 0.435 106.500 0.471
201903 0.561 107.700 0.600
201906 0.804 107.700 0.860
201909 0.881 109.800 0.925
201912 0.830 111.200 0.860
202003 0.627 112.300 0.643
202006 0.925 110.400 0.965
202009 0.516 111.700 0.532
202012 0.534 111.500 0.552
202103 0.746 112.662 0.763
202106 0.710 111.769 0.732
202109 0.596 112.215 0.612
202112 0.349 113.108 0.356
202203 0.583 114.335 0.588
202206 0.505 114.558 0.508
202209 0.861 115.339 0.860
202212 1.001 115.116 1.002
202303 0.869 115.116 0.870
202306 0.662 114.558 0.666
202309 0.538 115.339 0.537
202312 1.072 114.781 1.076
202403 0.973 115.227 0.973

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Jiangsu Wuzhong Pharmaceutical Development Co  (SHSE:600200) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Jiangsu Wuzhong Pharmaceutical Development Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Jiangsu Wuzhong Pharmaceutical Development Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Wuzhong Pharmaceutical Development Co (SHSE:600200) Business Description

Traded in Other Exchanges
N/A
Address
110 North Road, Soochow 7,8,10 Bank of China Building, Suzhou, Jiangsu, CHN, 215128
Jiangsu Wuzhong Industrial Co Ltd is a China-based company. It develops, produces and sells medicines while engages in real estate development.
Executives
Xu Liang Zhi senior management
Sun Jian Ying Supervisors
Zhong Yao Wen Supervisors
Cheng Xi senior management
Wu Jian Min Supervisors
Zhao Wei Yi Director
Jin Li Director
Sun Tian Jiang senior management
Zhu Ju Fang senior management
Yao Jian Lin Director
Jin Jian Ping Supervisors
Li Gui Zhi Supervisors
Luo Qin Supervisors
Xia Jian Ping Director
Zhong Shen Zheng Director

Jiangsu Wuzhong Pharmaceutical Development Co (SHSE:600200) Headlines

No Headlines